Asthma drug could help TB patients as well, find IISc scientists
The researchers at Indian Institute of Science, through extensive studies, have found that the anti-asthma drug, Pranlukast, destroys a specific metabolic pathway in Mycobacterium tuberculosis (Mtb), the causative agent of TB